Patterns and risk factors for noncompliance with HMG-CoA inhibitors in a managed care population

被引：0

作者：

Yu, AP ^{[1
]}

Nichol, MB ^{[1
]}

机构：

[1] Univ So Calif, Los Angeles, CA USA

来源：

关键词：

D O I：

10.1046/j.1524-4733.2003.00631.x

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：177 / 177

页数：1

共 50 条

[1] HMG-CoA reductase inhibitors and the risk of fractures
Meier, CR
Schlienger, RG
Kraenzlin, ME
Schlegel, B
Jick, H
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (24): : 3205 - 3210
[2] HMG-COA REDUCTASE INHIBITORS
ENDO, A
ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1985, 183 : 295 - 310
[3] HMG-COA REDUCTASE INHIBITORS
ENDO, A
HASUMI, K
NATURAL PRODUCT REPORTS, 1993, 10 (06) : 541 - 550
[4] HMG-CoA reductase inhibitors
Illingworth, DR
Tobert, JA
ADVANCES IN PROTEIN CHEMISTRY, VOL 56: DRUG DISCOVERY AND DESIGN, 2001, 56 : 77 - 114
[5] HMG-COA REDUCTASE INHIBITORS
GRUNDY, SM
JOURNAL OF INTERNAL MEDICINE, 1990, 228 (03) : 201 - 205
[6] HMG-COA REDUCTASE INHIBITORS
不详
BRITISH JOURNAL OF HOSPITAL MEDICINE, 1988, 40 (06): : 477 - 477
[7] HMG-CoA reductase inhibitors
不详
EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (01) : 77 - 78
[8] HMG-CoA reductase inhibitors and the risk of vertebral fracture
Schoofs, MWCJ
Sturkenboom, MCJM
van der Klift, M
Hofman, A
AP Pols, H
Stricker, BHC
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1525 - 1530
[9] Various HMG-CoA reductase inhibitors
Thiery, J
Seidel, D
INTERNIST, 1999, 40 (01): : 113 - 114
[10] HMG-CoA reductase inhibitors and the kidney
Vito M. Campese
Bassel Hadaya
Josephine Chiu
Current Hypertension Reports, 2005, 7 : 337 - 342